A University of Queensland study has shown that a deadly scorpion's venom carries an extra biochemical sting that could be ...

Scientists have uncovered the precise molecular trigger behind a rare blood-clotting disorder linked to certain COVID-19 vaccines.

Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.

Lipoprotein(a) or Lp(a) is a genetically controlled risk factor for a heart attack. Cardiologist explains why it's important to be aware of your levels.

The Johns Hopkins Armstrong Institute for Patient Safety and Quality leads national VTE prevention efforts through its Venous Thromboembolism (VTE) Collaborative, which aims to advance evidence-based ...

Increased demand for estrogen patches, particularly twice weekly doses, are in short supply nationally, causing delays for patients in Greater Boston.

RICE, rapid transport and a quick fridge check can change the outcome before a bleeding disorder turns into a major emergency ...

Research challenges the “low-risk” classification in type 2 diabetes, reporting fewer deaths and cardiac events with statins.

Testosterone therapy is booming in the U.S., but it might bring higher risks for people undergoing knee replacement surgery, ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

The U.S. Food and ​Drug Administration on ‌Thursday approved Johnson & Johnson's treatment ​for a ​type of blood ⁠cancer, ...